Other
18F-Choline PET-CT
18F-Choline PET-CT is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
unknownphase_2
Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients
NCT03344822
unknownnot_applicable
18F-fluorocholine PET/CT Imaging in Hyperparathyroidism
NCT03203668
completednot_applicable
Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer
NCT02232685
Clinical Trials (3)
Showing 3 of 3 trials
NCT03344822Phase 2
Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients
NCT03203668Not Applicable
18F-fluorocholine PET/CT Imaging in Hyperparathyroidism
NCT02232685Not Applicable
Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3